Tag Archives: tuberculosis

What We’re Reading: Cutting aid, cutting human rights, cutting disease-fighting efforts, and more . . .

By on .

UK to cut direct aid to South Africa – AIDS Alliance Response: While news that Britain plans to end direct aid to South Africa by 2015 was met with concern in opinion columns around the world, this piece from AIDS Alliance spells out why this will risk investments in the HIV response to date: the […]

Entrepreneur uses cell phones to fight counterfeit drugs while linking patients with answers

By on .

“In healthcare we have to work with what’s already happening” Nathan Sigworth was a freshman in college when he spent a month visiting a small hospital in India, and made a simple discovery: economics there dictated a very different delivery of health care than he was used to seeing. In time, he discovered that while […]

GeneXpert analysis puts numbers, consistency on test’s advantages

By on .

McGill University researchers who analyzed 18 studies involving more than 7,000 people released findings today showing the GeneXpert rapid diagnostic test for tuberculosis detected the disease among 67 percent of samples in which it had been missed by smear microscopy, the most common diagnostic tool in low-resource but high burden countries. While both tests require […]

Clinton launches Blueprint for AIDS-free generation: “Now we have to deliver”

By on .

Introducing the first formal strategy to tackle the global AIDS epidemic, U.S.  Secretary of State Hillary Clinton unveiled the PEPFAR Blueprint today, saying the plan would not have been possible without science, and that science will carry it forward. Clinton was joined by U.S. Global AIDS Ambassador Eric Goosby, South African AIDS treatment advocate Florence […]

Programs, research, funding for tuberculosis response leave children behind

By on .

When a disease spreads among people living in close quarters and poverty, the question of how hard it is hitting some of the most vulnerable people in its path seems obvious: How many children are suffering from, and dying of tuberculosis? The answer: Nobody seems to know. Numbers are just the tip of the iceberg […]

WHO 2012 Global Tuberculosis Report shows uneven progress

By on .

New cases of TB have been falling for several years, while access to care has expanded,  and deaths from tuberculosis have dropped by forty percent since the mid-1990s.  That’s some of the progress highlighted in the World Health Organization’s Global Tuberculosis Report released last week, and it means the target of halving the death rate […]

Keeping up with the Global Fund

By on .

After a tumultuous few years the Global Fund to Fight AIDS, Tuberculosis and Malaria is nearing completion of, at least, the first phases of a makeover, with the framework for a new funding model agreed upon at its September board meeting, and details of the model to be decided at the next, Nov. 14-15 board […]

Global Fund TB allocation shows need for work, action, groups say

By on .

When the Global Fund Board released its September meeting “decision points” document on funding allocation methods, it was, watchers noted, a part of a piece of a work in progress. But one decision will hold for the next year, and will impact efforts to roll out advances in tuberculosis diagnosis and treatment — the decision […]

Collaboration seeks to speed new TB treatments

By on .

About half a century has passed since a new tuberculosis drug was put to use, and in that time the challenges to successful treatment of the disease have only grown, with bacteria adapting faster to conditions that allowed it to flourish than science and funding for research. Morphing into forms that require from months to […]

TB advocates respond to Global Fund proposal for “historical disease allocation” model

By on .

As board members of the Global Fund to Fight AIDS, Tuberculosis and Malaria prepare to meet Thursday and Friday in Geneva, advocates for tuberculosis detection, treatment and prevention have signed a response to a proposal they say will foster a divisive “disease against disease” approach to funding, and seriously undermine efforts to roll out cost-effective […]